Aditxt Inc. CEO to Showcase Innovation at Wall Street Reporter’s NEXT SUPER STOCK Event

Aditxt Inc. (NASDAQ: ADTX), a platform focused on accelerating health innovations, has announced that its Co-founder and CEO, Amro Albanna, will be presenting at the NEXT SUPER STOCK livestream event hosted by Wall Street Reporter on June 26, 2025. The presentation will cover Aditxt's innovation acceleration model, progress in autoimmunity and early cancer detection programs, and details on the pending acquisition of Evofem Biosciences, Inc. This event is a significant opportunity for Aditxt to showcase its contributions to addressing critical health challenges through its unique innovation platform.

The company's approach involves a collaborative ecosystem that includes research institutions, industry partners, and shareholders, aiming to democratize innovation in the health sector. Aditxt's current programs focus on immune health and precision health, with plans to expand into public health and women's health through strategic agreements with Appili Therapeutics Inc. and Evofem Biosciences, Inc. These initiatives underscore Aditxt's commitment to developing and deploying innovative solutions to some of the most pressing health issues today.